Home Performance Evaluation of the Precision™ PCx™ Point-of-Care Blood Glucose Analyzer Using Discriminant Ratio Methodology
Article
Licensed
Unlicensed Requires Authentication

Performance Evaluation of the Precision™ PCx™ Point-of-Care Blood Glucose Analyzer Using Discriminant Ratio Methodology

  • Véronique Y. Miendje Deyi , Marianne Philippe , Kathy C. Alexandre , Philippe De Nayer and Michel P. Hermans
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 40 Issue 10

Abstract

Point-of-care glucose testing needs to be integrated into a laboratory information system to provide continuous care. Selecting a particular glucose monitoring system is based on both analytical performance and on user's preference. We evaluated accuracy, performance and regulatory compliance of the Precision™ PCx™ glucose analyzer (Abbott), with automatic download into a central station, for remote quality control (QC) management and automatic upgrading. We used the discriminant ratio (DR) methodology, which determines the DR of a test (e.g. the ratio between the underlying SD and the within-subject SD), and compares it to that of another test allegedly measuring the same parameter. Accuracy was evaluated by Clarke's error grid method. Seven hundred and ninety four blood samples were taken from 22 diabetic patients, combined with two capillary blood samples: one for analysis by reference method and the second for PCx™ analysis. Linear regression analysis revealed, over a 2.1 to 26.9 mmol/l glucose concentration range, a correlation coefficient of 0.963, an intercept of 0.7 mmol/l and a slope of 0.851. Mean difference between meter-generated results and the reference method was −7.1±10.8%. Between-run imprecision for PCx™ using Abbott's controls at low and mid-low concentrations was 5.4 and 3.8%, respectively. Clarke's error grid did not show any clinical impact related to difference between methods. DRs were of similar magnitude using both methods. Nursing staff found PCx™ easy for everyday use. Our data show that PCx™ results agree with those obtained with the reference method, as shown by lack of significant difference in DRs, and by excellent correlation.

:
Published Online: 2005-06-01
Published in Print: 2002-10-29

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. The 9th Asian Pacific Congress of Clinical Biochemistry
  2. Circulating DNA in Plasma and Serum: Biology, Preanalytical Issues and Diagnostic Applications
  3. Role of Steroid Hormones and Growth Factors in Breast Cancer
  4. Gene Polymorphism and Coronary Risk Factors in Indian Population
  5. Clinical Utility of Free Drug Monitoring
  6. Telomerase – a Potential Molecular Marker of Lung and Cervical Cancer
  7. Association of Polymorphisms in the Collagen Region of Human SP-A1 and SP-A2 Genes with Pulmonary Tuberculosis in Indian Population
  8. Effect of Hemodialysis on the Oxidative Stress and Antioxidants
  9. Total Iron Binding Capacity and Transferrin Concentration in the Assessment of Iron Status
  10. Increased Levels of Osteoprotegerin in Hemodialysis Patients
  11. Levels of Testosterone, Allopregnanolone and Homocysteine in Severe Hypothyroidism
  12. The Levels of Serum Vitamin C, Malonyldialdehyde and Erythrocyte Reduced Glutathione in Chronic Obstructive Pulmonary Disease and in Healthy Smokers
  13. Highly Specific, Simple and Rapid Method for the Determination of Malondialdehyde in Blood Using High-Performance Liquid Chromatography
  14. Precision and Accuracy of a HPLC Method for Measurement of Fecal Porphyrin Concentrations
  15. Continuous Age-Dependent Reference Ranges for Thyroid Hormones in Neonates, Infants, Children and Adolescents Established Using the ADVIA(r) Centaur(tm) Analyzer
  16. Diagnostic Value of Various Urine Tests in the Jordanian Population with Urinary Tract Infection
  17. Performance Evaluation of the Precision™ PCx™ Point-of-Care Blood Glucose Analyzer Using Discriminant Ratio Methodology
  18. Clinical Evaluation of a New Automated Anti-dsDNA Fluorescent Immunoassay
  19. Upper Reference Limits for Urinary Catecholamines, Metanephrines and 3-Methoxy-4-Hydroxymandelic Acid in Hypertensive Patients
  20. Growth Hormone Immunoassays: Proposal to Reduce Interlaboratory Variability
  21. Poetry, Images and Visions: William Blake
  22. Meetings and Awards
Downloaded on 6.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2002.184/html
Scroll to top button